January 1, 2020Open Access

Obacunone reduces inflammatory signalling and tumour occurrence in mice with chronic inflammation-induced colorectal cancer

Key Points

Key points are not available for this paper at this time.

Abstract

Obacunone could alleviate CRC via inhibiting inflammatory response and tumor cells proliferation. The results may contribute to the effective utilization of obacunone or its derivatives in the treatment of human CRC.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Luo et al. (Wed,) studied this question.

synapsesocial.com/papers/69dd545c656f15f1fc10113d https://doi.org/https://doi.org/10.1080/13880209.2020.1812673

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Detecting Hematopoietic Stem Cell Proliferation Using BrdU Incorporation2017 · 33 citations
2Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme2010 · 1,032 citations
3<p>Metabonomic Variation of Exopolysaccharide from <em>Rhizopus nigricans</em> on AOM/DSS-Induced Colorectal Cancer in Mice</p>2019 · 11 citations
4Protective Effect of Zingiber officinale Against Dalton’s Lymphoma Ascites Tumour by Regulating Inflammatory Mediator and Cytokines2016 · 14 citations
5The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety2014 · 3,784 citations

Bookmark

View Full Paper